Menlo Park-based Auxogyn and Darmstadt, Germany's Merck Serono will work together on the Early Embryo Viability Assessment, or Eeva Test. It was approved in July by European regulators -- getting the CE mark which allows it to be sold in the European Union -- and it is pending before the U.S. Food and Drug Administration.
No comments:
Post a Comment